[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"facial-scarring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:facial-scarring":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100629247",false,"NCT07472192","Comparative Study for Facial Scar Remodeling Using Fractional Carbon Dioxide Laser Combined With PDRN Versus Fractional CO₂ Laser","Comparative Study for Facial Scar Remodeling Using Fractional Carbon Dioxide Laser Combined With Polydeoxyribonucleotide (PDRN) Versus Fractional CO₂ Laser: A Randomized Controlled Clinical Study","PDRN CO2 LASER","Inclusion Criteria:\n\n* Age Limitations: Participants must be between 18 and 50 years of age.\n* Recently cut wounds or surgical scars from about (1-6 months).\n* Consent to Participate: Willingness to provide informed consent and engage in all aspects of the study.\n\nExclusion Criteria:\n\n* Pregnancy or breastfeeding at the time of study.\n* Known allergy to PDRN.\n* Medication use that could affect wound healing or inflammation, such as:\n\n  * Isotretinoin.\n  * Anticancer drugs.\n  * High-dose corticosteroids.\n  * Anticoagulants.\n* Uncontrolled medical diseases (e.g., unstable diabetes, cardiac conditions).","ALL","18 Years","50 Years",{"count":20,"type":21},36,"ESTIMATED","INTERVENTIONAL",[24],"PHASE2","Facial scars are frequently deemed unpleasant and can profoundly impact a patient's psychological health. This study compares the effectiveness, safety, and capacity to speed up scar healing in the maxillofacial region between fractional carbon dioxide (CO₂) laser therapy alone and polydeoxyribonucleotide (PDRN) combined with CO₂ laser therapy.",[27],"Facial Scarring","RECRUITING","2026-03-11",{"date":31,"type":32},"2026-03-16","ACTUAL",{"date":34,"type":32},"2026-03-01",{"date":36,"type":21},"2026-07-01",{"name":38,"class":39},"Misr University for Science and Technology","OTHER",""]